# Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)

> **NCT05175014** · PHASE4 · COMPLETED · sponsor: **Epicentre** · enrollment: 44618 (actual)

## Conditions studied

- Pneumococcal Carriage

## Interventions

- **BIOLOGICAL:** PCV10 full dose
- **BIOLOGICAL:** PCV10 fractional dose

## Key facts

- **NCT ID:** NCT05175014
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-30
- **Primary completion:** 2023-03-14
- **Final completion:** 2023-10-03
- **Target enrollment:** 44618 (ACTUAL)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175014, "Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05175014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*